ASBMT news  by unknown
2004 TANDEM BMT MEETINGS
WILL BE FEB. 13–17 IN ORLANDO
The combined 2004 annual meet-
ings of ASBMT and the International
Bone Marrow Transplant Registry/Au-
tologous Blood and Marrow Trans-
plant Registry (IBMTR/ABMTR) will be
Feb. 13–17 at the Coronado Springs
Resort in Orlando.
The abstracts deadline is Oct. 20,
2003.
Scientific Topics
Recent advances in the broad field
of cellular therapy and blood and
marrow transplantation will be ad-
dressed in plenary sessions, concur-
rent sessions, workshops, poster ses-
sions and symposia. Topics include:
Treatment of Hematologic Malignan-
cies
• Acute lymphoblastic leukemia
• Acute myelogenous leukemia
• Chronic myelogenous leukemia
• Multiple myeloma
Graft-vs-Host Disease
• Animal models
• New therapies
Issues in Analyzing Transplant Data
• Medical decision making
• Biostatistical techniques
Management of Transplant-Related
Complications
• Cellular therapy for infectious disease
• Monitoring and treating late effects
Transplant Biology
• Tolerance induction/regulatory T-
cells
• Post-transplant immune reconstitu-
tion
• Minor antigens
• Chemokines and mechanisms of
mobilization
• HLA and alternative donor trans-
plantation
• Natural killer cells
Hematopoiesis
• Multipotent stem cell biology
• Mesenchymal stem cells
Gene Therapy
Tumor Vaccines
Health Care Resources
Related Conferences
In addition to the five days of scien-
tific sessions for BMT clinicians and
investigators, there will be five related
conferences and courses:
• BMT Pharmacists (Feb. 12–13)
• Clinical Research Associates Data
Management (Feb. 12–14)
• BMT Center Medical Directors (Feb.
13)
• BMT Center Administrators (Feb.
14–15)
• Oncology Nursing (Feb. 15–17)
Early Registration Deadline
Online meeting registration opens
Aug. 1 at both the ASBMT Web site,
www.asbmt.org, and the IBMTR/
ABMTR Web site, www.ibmtr.org.
The early registration deadline is Oct.
20, 2003.
Abstracts Deadline
Abstracts can be submitted online
beginning Aug. 1 at the ASBMT and
the IBMTR/ABMTR Web sites. The ab-
stracts deadline also is Oct. 20, 2003.
Housing at Coronado Springs
Resort
The distinctive Coronado Springs
Resort is adjacent to Disney’s Animal
Kingdom and only minutes away
from Epcot and Disney-MGM Studios
and other area attractions but a uni-
verse apart from the bustle and com-
motion of the Disney World crowds.
The housing deadline is Jan. 12,
2004, after which accommodations
are on a space-available basis. Down-
load and print the Housing Reserva-
tion Form from either the ASBMT or
IBMTR/ABMTR Web site. Reservations
also can be phoned to the Coronado
Springs Resort at (407) 939-1020,
faxed to (407) 939-1012, or sent
by e-mail to wdw.cgr@disney.com.
Mention the Tandem BMT Meetings
to obtain special conference rates.
Information about the Tandem
BMT Meetings will be continuously
updated on the ASBMT Web site at
www.asbmt.org.
Preliminary Program
The scientific program chair for
ASBMT is Robert Negrin, MD, Stanford
University, and the co-chairs for the
IBMTR/ABMTR are Richard Champlin,
MD, M.D. Anderson Cancer Center,
and Olle Ringde´n, MD, PhD, Hud-
dinge University Hospital in Stock-
holm, Sweden.
In addition to the program high-
lights listed below, 66 original ab-
stracts will be selected for oral presen-
tation.
FRIDAY, FEBRUARY 13
• Hematopoiesis
Stephen Emerson
• Acute Lymphoblastic Leukemia
Kari Blume
• Natural Killer Cells
Peter Parham, Jeffrey Miller, Ales-
sandro Moretta
• Mesenchymal Stem Cells
Edwin Horwitz
• Medical Decision Making: What Do
We Need To Know To Make Tough
Choices?
Stephanie Lee, Corey Cutler
• New Approaches to the Treatment
of Acute GvHD
Joseph Antin, Daniel Weisdorf
SATURDAY, FEBRUARY 14
• Immunogenetics of Hematopoietic
Cell Transplantation
Effie Petersdorf, Yasuo Morishima,
Mary Carrington
• Recent Advances in Treatment of
Adult and Pediatric AML
Gary Gilliland, Martin Tallman, Rob-
ert Arceci
• Tolerance Induction/Regulatory T-
Cells
Carl June, Bruce Blazar, Lee Nadler
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SUNDAY, FEBRUARY 15
• The Role of BMT for CML in the
Gleevec Era
Richard Champlin
• Clinical Resource Challenges:
2004
C. Fred LeMaistre, Andrew Pecora,
John Wingard
• Minor Histocompatibility Antigens
Stanley Riddell, Claude Perreault,
Yoshiki Akatsuka
• Animal Models for GvHD/GvL: How
Relevant Are They for Clinical
HSCT?
Marcel Van den Brink, Robert Korn-
gold
• Statistical Issues in Bone Marrow
Transplantation
John Klein
• Chemokines – Mechanisms of Mo-
bilization
Robert Negrin
• National Marrow Donor Program
Daniel Weisdorf, Stella Davies
MONDAY, FEBRUARY 16
• New Treatment Strategies for Mul-
tiple Myeloma
Kenneth Anderson, Jean Luc Har-
rouseau, William Bensinger
• Immune Reconstitution
Kenneth Weinberg, Warren Pear,
Steven Reiner, Leslie Berg
• Gene Therapy
Christof von Kalle
TUESDAY, FEBRUARY 17
• Multipotent Stem Cell Biology
Edwin Scott
• Cellular Therapy for Infectious Dis-
ease
Hermann Einsele, Richard O’Reilly,
Stanley Riddell
• Late Effects: Are We Doing Enough
for Our Survivors?
J. Douglas Rizzo, Ge´rard Socie´
• Tumor Vaccines after BMT
Jeffrey Molldrem
• International Session
ASBMT, EBMT, IBMTR/ABMTR
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